Vishnu Chemicals Limited — PPTs, 24-01-2025: Investor Presentation

**Financial Highlights:** For Q3FY25, Vishnu Chemicals reported consolidated operating revenues of ₹371.22 Cr, a 22% increase YoY and 8% QoQ. EBITDA surged to ₹63.50 Cr, up 55% YoY, with an impressive EBITDA margin of 17.1%. PAT reached ₹34.40 Cr, marking a 66% rise from the previous year, with a PAT margin of 9.3%.

**Strategic Initiatives and Growth Drivers:** The company continues to focus on manufacturing efficiencies, a flexible product mix, and geographic diversification, enhancing resilience against market headwinds. A recent acquisition, Jayansree Pharma Pvt Ltd, and ongoing statutory approvals for a South Africa expansion signal growth potential.

**Business Developments:** Performance in the domestic market outpaced that of exports, with a domestic-export sales mix of 61:39 in Q3FY25. Both Chromium and Barium Chemicals demonstrated improved profitability, aided by operational enhancements.

**Market Position and Competitive Advantage:** Vishnu Chemicals maintains a strong foothold in the specialty chemicals segment, leveraging its multi-site manufacturing capabilities and commitment to customer-focused solutions.

**Investor Implications:** The company's stable performance, along with effective management strategies and improved margins, presents a positive outlook for investors. The recent credit rating upgrades and consistent dividend track record further enhance the investment appeal.